VCM
MACK

Virtue Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Virtue Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,451
Closed -$151K – 694
2017
Q4 		$151K Buy
+4,451
New +$151K 0.09% 186